Speech Therapy Pediatric denied as duplicate or overlapping therapy by Cigna?

Cigna's specific coverage criteria for speech therapy pediatric are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denies Pediatric Speech Therapy as Duplicate Therapy

A "duplicate therapy" denial means Cigna's reviewer has determined that the child is already receiving a service that it considers equivalent to the requested speech therapy — most commonly school-based speech services provided under an Individualized Education Program (IEP) or a separate outpatient therapy authorization already in place. This is one of the most frequently contested and most frequently overturned denial reasons in pediatric therapy, because school-based IEP services and clinical speech therapy serve different purposes, are governed by different regulatory frameworks, and are not interchangeable.

School services are provided under IDEA (Individuals with Disabilities Education Act) for educational purposes. Clinical speech therapy addresses medical diagnoses, functional communication, and health outcomes. Courts, external reviewers, and state insurance commissioners have repeatedly held that these are not duplicates.

## Your Appeal Rights

• Internal appeal (ACA §2719 / ERISA §503): File a written internal appeal with documentation distinguishing clinical from educational services. Cigna must provide a full-and-fair review.
• External review: After internal denial, request independent external review by an IRO. External reviewers apply clinical standards and consistently recognize that IEP services do not constitute a clinical duplicate. File within the window on your Explanation of Benefits — typically approximately four months.
• Expedited review: If the denial is causing interruption of active treatment for a child with a time-sensitive developmental window, invoke expedited review and document the clinical urgency.
• Mental Health Parity / MHPAEA: If the speech disorder relates to autism, developmental disability, or another behavioral health condition, federal mental health parity law (MHPAEA) prohibits applying treatment limitations that are more restrictive than those applied to analogous medical/surgical services.

## Documentation to Gather

1. Diagnosis confirmation: The treating SLP's or pediatrician's documentation of the underlying diagnosis (e.g., language disorder, apraxia, articulation disorder, autism spectrum disorder) — a medical diagnosis, not merely an educational classification. 2. Distinction from IEP services: A letter from the treating speech-language pathologist (SLP) explaining specifically what the clinical therapy addresses that the school's IEP services do not — goals, frequency, intensity, and clinical outcomes are all relevant. 3. IEP documentation: A copy of the child's IEP showing the scope and goals of school-based services, so the reviewer can see they are educationally, not medically, focused. 4. Treatment plan and progress notes: The clinical SLP's treatment plan showing medical goals and recent session notes documenting progress and ongoing clinical need. 5. Prescriber/pediatrician referral: The referring physician's documentation of medical necessity.

## Criteria-Mapping Structure

Obtain Cigna's published coverage policy for pediatric speech therapy. Copy each criterion. For each, document the specific chart evidence. Specifically address the "duplicate" allegation with a side-by-side comparison: school service goals versus clinical service goals — demonstrating they are not the same service.